Kathleen Ford
Vermögen: 2 Mio $ am 30.06.2026
Vermögen: 2 Mio $ am 30.06.2026
Kathleen Ford is Chief Operating Officer at Kura Oncology, Inc. since 2019.
Formerly, Ms. Ford was Senior VP & Head-Global Clinical Operations at Merck Healthcare Germany GmbH from 2012 to 2017, Vice President-Clinical Operations at Millennium Pharmaceuticals, Inc. from 2002 to 2009, and Director-Clinical Operations at Alkermes Plc from 1993 to 2002.
Ms. Ford completed undergraduate education at Fitchburg State College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KURA ONCOLOGY, INC. 0,17 % | 19.05.2026 | 153 560 ( 0,17 % ) | 2 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| KURA ONCOLOGY, INC. | Geschäftsführer | 09.08.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
Merck Serono GmbH
Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 |
| ALKERMES PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2002 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Kura Oncology, Inc.
Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Fitchburg State College
Fitchburg State College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alkermes Plc
Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Merck Serono GmbH
Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen